Spiramycin

CAS: 8025-81-8

Ref. IN-DA00IKH4

Produktinformation

• Name: Spiramycin
• Synonyme: Rovamycin, Rovamycine, Selectomycin, Spiramycin Adipate, Spiramycine, Espiramicin, Provamycin, Sequamycin, Spiramycine, Spiramycinum, Rovamycin, Rovamycine, Spiramycin antibiotic complex, Spiramycin, Pharmaceutical Secondary Standard; Certified Reference Material, 2-[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[5-(4,5-dihydroxy-4,6-dimethyloxan-2-yl)oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde, Espiramicina, Foromacidin, Leucomycin, Spiramycin I, Antibiotic 799, Il 5902, Nsc 55926, Rovamicina, Rp 5337, Spiramycin Base, Spiramycin Standard Solution, Spiramycin solution, Spiramycins, Stomamycin, [(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-({5-[(4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl}oxy)-10-{[5-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-dien-7-yl]acetaldehyde (non-preferred name), [(4R,5S,6S,7R,9R,10R,11E,13E,16S)-6-{[(2S,3R,4R,5S,6R)-5-{[(2S,4R,5R,6S)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-10-{[(2R,5S,6R)-5-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-dien-7-yl]acetaldehyde (non-preferred name)
• Marke: Indagoo

Chemische Eigenschaften

• Molekulargewicht: 843.0527
• Formel: C₄₃H₇₄N₂O₁₄
• Reinheit: 90.0%
• Farbe/Form: Solid
• InChl: InChI=1S/C43H74N2O14/c1-24-21-29(19-20-46)39(59-42-37(49)36(45(9)10)38(27(4)56-42)58-35-23-43(6,51)41(50)28(5)55-35)40(52-11)31(47)22-33(48)53-25(2)15-13-12-14-16-32(24)57-34-18-17-30(44(7)8)26(3)54-34/h12-14,16,20,24-32,34-42,47,49-51H,15,17-19,21-23H2,1-11H3/b13-12+,16-14+/t24-,25-,26?,27?,28?,29+,30?,31-,32+,34?,35?,36?,37?,38?,39+,40+,41?,42?,43?/m1/s1
• InChI Key: ACTOXUHEUCPTEW-JMRHEKERSA-N